Tag
Granules India Limited
2 articles
Granules India's US Facility Completes FDA Audit with 4 Observations
Granules India's US subsidiary, Granules Pharmaceuticals, Inc., has completed a routine cGMP audit by the US FDA at its Chantilly facility.
The audit, conducted from March 30 to April 3, 2026, resulte
Granules Life Sciences Gets US FDA VAI Classification
Granules Life Sciences Private Limited (GLS), a wholly owned subsidiary of Granules India, received VAI classification from US FDA for its Shamirpet, Telangana facility.
The Establishment Inspection R